CITATION:  AHS COVID-19 Antimicrobial Management Working Group, Alberta Health Services. Current Guidance for the Management of Adult Hospitalized Patients with COVID-19.  Last updated September 2021.


PHAC/AMMI/CCCS COVID-19 information for health professionals  


Infectious Diseases Society of America (IDSA) guidelines


WHO COVID-19 technical guidance  


AHS Guidance for the Management of Adult Hospitalized Patients with COVID-19


The guidance provided herein does not replace best clinical judgment and/or expert consultation but rather is meant to inform clinicians of the most current management guidelines to facilitate best use of therapeutic options for patients with COVID-19.


Consultation with other specialties (e.g. Infectious Diseases, Respiratory Medicine, Critical Care, General Internal Medicine) who are most likely to be familiar with the rapidly evolving literature can be considered to help assess the risks and benefits for an individual patient. Any off-label use of medication requires the prescriber’s careful consideration of risk/benefit, consultation between experts and attending physician as needed, and documenting consent from the patient or caregiver after discussion of the current state of evidence of benefit and harms. Adverse events with respect to off-label use of medications for inpatient treatment should be documented and reported by clinicians.


Supportive care remains an important component of therapy for individuals infected with SARS-CoV-2.